BLFS vs NVST
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
BLFS · BioLife Solutions$0.00 ▲ 0.00%
NVST · Envista Holdings$22.91 ▼ 1.55%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- BLFS +46.5%
- NVST +14.1%
Head to head
| Metric | BLFS | NVST |
|---|---|---|
| Price | $0.00 | $22.91 |
| Change today | ▲ 0.00% | ▼ 1.55% |
| Market cap | $1.89B | $3.67B |
| Return, 3 months | +42.0% | -16.2% |
| Return, year to date | +59.7% | +5.5% |
| Return, 1 year | +46.8% | +15.2% |
| P/E (TTM) | 32.7 | 6.0 |
| P/B | 4.5 | 1.2 |
| P/E percentile vs own 5y | 92nd | 30th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +21.5% | +3.2% |
| Net profit growth (YoY) | +384.8% | +1,777.6% |
| Gross margin | 63.6% | 55.9% |
| Operating margin | 1.6% | 11.2% |
| Net margin | 54.3% | 22.0% |
| Return on equity | 15.1% | 20.5% |
| Analyst target vs. price | – | +31.4% |
| Analyst buy share | 0% | 58% |
| RSI (14) | 61 | 40 |
| 30-day volatility | 30.6% | 49.9% |
| Max drawdown, 1 year | -37.0% | -26.0% |
| Trend read | Strong uptrend | Strong downtrend |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- NVST is the largest of the group by market value.
- BLFS has returned the most over the past year.
- NVST carries the lowest trailing P/E.
- BLFS is growing revenue fastest.
- BLFS keeps the most profit per dollar of sales.
- BLFS has been the calmest stock over the last 30 days.